arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Haemonetics Corporation

HAE Health Care Medical/Dental Instruments
$102.92
▼ -0.0% Today
as of Sep 4, 16:49 ET
Last 30 days +24.69% Jul 28 → Sep 04
$80.44 $88.05 $95.67 $103.29 $110.90 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$101.59
High
$103.56
Low
$101.51
Volume
$423,177
Avg Vol
$866,798
Mkt Cap
$4.1B
P/E (TTM)
41.50
Beta
—
52w High
$109.57
52w Low
$47.32
Div Yield
—
Shares Out
$45M

Recent Press Releases & News last 60 days · 25 items

Aug 31 · 15:40 Zacks
GEHC vs. HAE: Which Stock Is the Better Value Option?
Aug 21 · 19:55 StockStory
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Aug 19 · 11:34 MT Newswires
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$47
$110
89% of range
Avg surprise (last 3)
+3.8%
Avg reaction (last 2)
+4.5%
100% positive
Latest IV / EM
29%
EM ±4.5% · $105 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.48$0.68$0.89$1.09$1.29 Actual $0.80Actual $0.48Actual $0.61Actual $0.74Actual $0.66Actual $0.74Actual $1.24Est $1.22Actual $1.10Est $1.01Actual $0.81Actual $0.95Actual $1.29Est $1.28Actual $0.72 JulSepDecJunSepDecMar/2025Jun/2025SepDecMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$91M$183M$274M$366M Sep 24Dec 24Jun 25Sep 25Dec 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Sat Jun 27, 2026Jun 2026 $0.72 — — — — financials
Thu May 7, 2026Mar/2026 $1.29 $1.28 +0.8% +4.0% +3.2% earnings
Sat Dec 27, 2025Dec 2025 $0.95 — — — — financials
Sat Sep 27, 2025Sep 2025 $0.81 — — — — financials
Thu Aug 7, 2025Jun/2025 $1.10 $1.01 +8.9% — — earnings
Thu May 8, 2025Mar/2025 $1.24 $1.22 +1.6% — +5.9% earnings
Sat Dec 28, 2024Dec 2024 $0.74 — — — — financials
Sat Sep 28, 2024Sep 2024 $0.66 — — — — financials
Sat Jun 29, 2024Jun 2024 $0.74 — — — — financials
Sat Dec 30, 2023Dec 2023 $0.61 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.48 — — — — financials
Sat Jul 1, 2023Jul 2023 $0.80 — — — — financials
Sat Dec 31, 2022Dec 2022 $0.64 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$339M—$339M$327M$321M—$349M$346M
Cost of revenue$137M—$137M$133M$129M—$155M$158M
Gross profit$203M—$202M$195M$192M—$194M$187M
Operating income$57M—$67M$58M$54M—$59M$52M
Net income$33M—$45M$39M$34M—$37M$34M
EPS (diluted)$0.72—$0.95$0.81$0.70—$0.74$0.66

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$223M$245M$363M$296M$293M$307M$321M$299M
Inventory$307M$306M$321M$336M$361M$365M$360M$382M
Total current assets$811M$835M$944M$900M$913M$935M$1.01B$956M
Total assets$2.37B$2.40B$2.49B$2.44B$2.46B$2.45B$2.53B$2.53B
Long-term debt$1.17B$1.22B$920M$920M$921M$921M$1.22B$1.22B
Total liabilities————————
Total equity$837M$796M$911M$849M$882M$821M$907M$879M

Implied volatility — last 90 days

29%54%80%106%131% Jun 07 — IV 58% · EM ±8.0%Jun 08 — IV 50% · EM ±6.5%Jun 09 — IV 46% · EM ±5.8%Jun 10 — IV 54% · EM ±6.3%Jun 11 — IV 54% · EM ±6.0%Jun 12 — IV 65% · EM ±6.7%Jun 15 — IV 111% · EM ±8.0%Jun 16 — IV 80% · EM ±4.7%Jun 17 — IV 132% · EM ±5.5%Jun 19 — IV 41% · EM ±9.0%Jun 22 — IV 41% · EM ±8.6%Jun 23 — IV 44% · EM ±9.1%Jun 24 — IV 42% · EM ±8.3%Jun 25 — IV 43% · EM ±8.4%Jun 26 — IV 46% · EM ±8.8%Jun 29 — IV 43% · EM ±7.6%Jun 30 — IV 40% · EM ±6.9%Jul 01 — IV 41% · EM ±6.9%Jul 02 — IV 46% · EM ±7.4%Jul 03 — IV 47% · EM ±7.4%Jul 06 — IV 50% · EM ±6.9%Jul 07 — IV 46% · EM ±6.0%Jul 08 — IV 47% · EM ±5.9%Jul 09 — IV 46% · EM ±5.4%Jul 10 — IV 40% · EM ±4.4%Jul 13 — IV 89% · EM ±7.4%Jul 14 — IV 46% · EM ±3.3%Jul 15 — IV 103% · EM ±6.1%Jul 16 — IV 108% · EM ±4.5%Jul 20 — IV 63% · EM ±14.9%Jul 21 — IV 58% · EM ±13.5%Jul 22 — IV 66% · EM ±15.1%Jul 23 — IV 65% · EM ±14.7%Jul 24 — IV 65% · EM ±14.3%Jul 27 — IV 67% · EM ±13.9%Jul 28 — IV 64% · EM ±13.1%Jul 29 — IV 63% · EM ±12.6%Jul 30 — IV 67% · EM ±13.1%Jul 31 — IV 66% · EM ±12.6%Aug 03 — IV 74% · EM ±13.2%Aug 04 — IV 73% · EM ±12.6%Aug 05 — IV 73% · EM ±12.2%Aug 06 — IV 47% · EM ±7.6%Aug 07 — IV 41% · EM ±6.4%Aug 10 — IV 50% · EM ±7.0%Aug 11 — IV 48% · EM ±6.3%Aug 12 — IV 42% · EM ±5.3%Aug 13 — IV 43% · EM ±5.1%Aug 14 — IV 43% · EM ±4.7%Aug 17 — IV 45% · EM ±3.7%Aug 18 — IV 57% · EM ±4.1%Aug 19 — IV 69% · EM ±4.1%Aug 20 — IV 50% · EM ±2.1%Aug 24 — IV 36% · EM ±7.4%Aug 25 — IV 35% · EM ±7.2%Aug 26 — IV 32% · EM ±6.5%Aug 27 — IV 31% · EM ±6.1%Aug 28 — IV 31% · EM ±6.0%Aug 31 — IV 29% · EM ±5.2%Sep 01 — IV 37% · EM ±6.4%Sep 02 — IV 34% · EM ±5.8%Sep 03 — IV 37% · EM ±6.0%Sep 04 — IV 29% · EM ±4.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in